$NURO
NeuroMetrix, Inc. Stock $nuro

$nuro Overview Financials Valuation SEC Filings Company Website

2019 Q4 Form 10-Q Financial Statement

#000162828019012340 Filed on October 17, 2019

Income Statement

Concept	2019 Q4	2019 Q3	2018 Q3
Revenue	$1.710M	$2.088M	$3.667M
YoY Change	-54.16%	-43.06%	3.39%
Cost Of Revenue	$640.0K	$914.3K	$1.821M
YoY Change	-67.68%	-49.79%	-10.77%
Gross Profit	$1.060M	$1.174M	$1.846M
YoY Change	-39.43%	-36.41%	22.58%
Gross Profit Margin	61.99%	56.21%	50.33%
Selling, General & Admin	$1.820M	$2.111M	$3.350M
YoY Change	-48.15%	-36.99%	-19.82%
% of Gross Profit	171.7%	179.83%	181.5%
Research & Development	$630.0K	$475.1K	$1.178M
YoY Change	-40.57%	-59.68%	40.2%
% of Gross Profit	59.43%	40.48%	63.85%
Depreciation & Amortization	$20.00K	-$10.00K	$30.00K
YoY Change		-133.33%	-57.14%
% of Gross Profit	1.89%	-0.85%	1.63%
Operating Expenses	$2.460M	$2.586M	$4.528M
YoY Change	-46.17%	-42.9%	-9.77%
Operating Profit	-$1.400M	-$1.412M	-$2.683M
YoY Change	-50.35%	-47.36%	-23.63%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net	$0.00	$7.464K	$20.00K
YoY Change	-100.0%	-62.68%
Pretax Income	-$1.060M	-$1.400M	$1.090M
YoY Change	-62.14%	-228.44%	-131.05%
Income Tax
% Of Pretax Income
Net Earnings	-$1.060M	-$1.405M	$1.086M
YoY Change	-62.14%	-229.33%	-130.95%
Net Earnings / Revenue	-61.99%	-67.27%	29.62%
Basic Earnings Per Share		-$0.14	$0.15
Diluted Earnings Per Share	-$1.093M	-$0.14	$0.08
COMMON SHARES
Basic Shares Outstanding	9.782M shares	978.2K shares	7.365M shares
Diluted Shares Outstanding		978.2K shares	13.95M shares

Balance Sheet

Concept	2019 Q4	2019 Q3	2018 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$3.130M	$3.190M	$7.530M
YoY Change	-53.83%	-57.64%	89.67%
Cash & Equivalents	$3.126M	$3.187M	$7.531M
Short-Term Investments
Other Short-Term Assets	$650.0K	$670.0K	$830.0K
YoY Change	-24.42%	-19.28%	-59.31%
Inventory	$1.164M	$1.079M	$2.597M
Prepaid Expenses
Receivables	$299.0K	$524.0K	$1.616M
Other Receivables	$190.0K	$1.180M	$0.00
Total Short-Term Assets	$5.431M	$6.636M	$12.57M
YoY Change	-53.13%	-47.22%	52.93%
LONG-TERM ASSETS
Property, Plant & Equipment	$273.4K	$299.3K	$380.5K
YoY Change	-32.87%	-21.34%	-8.82%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$30.00K	$30.00K	$90.00K
YoY Change	0.0%	-66.67%	-30.77%
Total Long-Term Assets	$1.463M	$1.871M	$466.7K
YoY Change	-39.19%	300.86%	-15.45%
TOTAL ASSETS
Total Short-Term Assets	$5.431M	$6.636M	$12.57M
Total Long-Term Assets	$1.463M	$1.871M	$466.7K
Total Assets	$6.894M	$8.507M	$13.04M
YoY Change	-50.73%	-34.76%	48.62%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$725.7K	$638.5K	$1.151M
YoY Change	-44.1%	-44.53%	58.74%
Accrued Expenses	$1.444M	$2.613M	$1.921M
YoY Change	-12.99%	35.99%	0.54%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$3.447M	$3.915M	$4.179M
YoY Change	-47.72%	-6.31%	-1.8%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$920.0K	$1.020M
YoY Change	-29.23%
Total Long-Term Liabilities	$920.0K	$1.020M	$0.00
YoY Change	-29.23%
TOTAL LIABILITIES
Total Short-Term Liabilities	$3.447M	$3.915M	$4.179M
Total Long-Term Liabilities	$920.0K	$1.020M	$0.00
Total Liabilities	$4.363M	$4.933M	$4.179M
YoY Change	-44.72%	18.06%	-1.8%
SHAREHOLDERS EQUITY
Retained Earnings	-$194.8M	-$193.7M	-$188.2M
YoY Change	1.98%	2.94%	-0.16%
Common Stock	$140.00	$978.00	$737.00
YoY Change	89.19%	32.7%	242.79%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$2.530M	$3.574M	$8.860M
YoY Change
Total Liabilities & Shareholders Equity	$6.894M	$8.507M	$13.04M
YoY Change	-50.73%	-34.76%	48.62%

Cashflow Statement

Concept	2019 Q4	2019 Q3	2018 Q3
OPERATING ACTIVITIES
Net Income	-$1.060M	-$1.405M	$1.086M
YoY Change	-62.14%	-229.33%	-130.95%
Depreciation, Depletion And Amortization	$20.00K	-$10.00K	$30.00K
YoY Change		-133.33%	-57.14%
Cash From Operating Activities	-$60.00K	-$1.740M	$380.0K
YoY Change	-91.67%	-557.89%	-113.24%
INVESTING ACTIVITIES
Capital Expenditures	-$10.00K	-$30.00K	$20.00K
YoY Change	-66.67%	-250.0%	-166.67%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$10.00K	-$30.00K	$20.00K
YoY Change	-66.67%	-250.0%	-166.67%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	10.00K	0.000	10.00K
YoY Change	0.0%	-100.0%	-99.69%
NET CHANGE
Cash From Operating Activities	-60.00K	-1.740M	380.0K
Cash From Investing Activities	-10.00K	-30.00K	20.00K
Cash From Financing Activities	10.00K	0.000	10.00K
Net Change In Cash	-60.00K	-1.770M	410.0K
YoY Change	-91.89%	-531.71%	13.89%
FREE CASH FLOW
Cash From Operating Activities	-$60.00K	-$1.740M	$380.0K
Capital Expenditures	-$10.00K	-$30.00K	$20.00K
Free Cash Flow	-$50.00K	-$1.710M	$360.0K
YoY Change	-92.75%	-575.0%	-112.68%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Address Address Line1 EntityAddressAddressLine1	4B Gill Street
CY2019Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	9781755	shares
	dei	Document Type DocumentType	10-Q
	dei	Entity Address City Or Town EntityAddressCityOrTown	Woburn
	dei	Amendment Flag AmendmentFlag	false
	dei	City Area Code CityAreaCode	781
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2019
	dei	Document Period End Date DocumentPeriodEndDate	2019-09-30
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	01801
	dei	Entity Address State Or Province EntityAddressStateOrProvince	MA
	dei	Entity Central Index Key EntityCentralIndexKey	0001289850
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity File Number EntityFileNumber	001-33351
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Registrant Name EntityRegistrantName	NeuroMetrix, Inc.
	nuro	Increase Decreasein Accrued Product Returns IncreaseDecreaseinAccruedProductReturns	-438352	USD
CY2018Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	407339	USD
	dei	Entity Shell Company EntityShellCompany	false
	nuro	Increase Decrease In Collaboration Receivable IncreaseDecreaseInCollaborationReceivable	1174092	USD
	nuro	Increase Decreasein Accrued Product Returns IncreaseDecreaseinAccruedProductReturns	-852596	USD
CY2019Q3	nuro	Technology Fees TechnologyFees	450000	USD
CY2018Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1298084	USD
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	043308180
	dei	Local Phone Number LocalPhoneNumber	890-9989
	dei	Trading Symbol TradingSymbol	NURO
CY2018Q4	nuro	Accrued Sales Return Provisions AccruedSalesReturnProvisions	1101658	USD
CY2019Q3	nuro	Accrued Sales Return Provisions AccruedSalesReturnProvisions	663306	USD
CY2018Q3	nuro	Collaboration Income CollaborationIncome	3750000	USD
	nuro	Collaboration Income CollaborationIncome	12255704	USD
CY2019Q3	nuro	Collaboration Income CollaborationIncome	0	USD
	nuro	Collaboration Income CollaborationIncome	7116667	USD
CY2018Q4	nuro	Collaborator Payments Receivable CollaboratorPaymentsReceivable	0	USD
CY2019Q3	nuro	Collaborator Payments Receivable CollaboratorPaymentsReceivable	1174092	USD
CY2018Q4	nuro	Contract Manufacturer ContractManufacturer	160000	USD
CY2019Q3	nuro	Contract Manufacturer ContractManufacturer	455000	USD
CY2018Q4	nuro	Deferred Collaboration Income DeferredCollaborationIncome	1956522	USD
CY2019Q3	nuro	Deferred Collaboration Income DeferredCollaborationIncome	0	USD
CY2019Q2	nuro	Facility Relocation Costs FacilityRelocationCosts	225000	USD
	nuro	Facility Relocation Costs FacilityRelocationCosts	225000	USD
	nuro	Increase Decrease In Collaboration Receivable IncreaseDecreaseInCollaborationReceivable	0	USD
CY2019Q3	nuro	Operating Lease Discount OperatingLeaseDiscount	544309	USD
CY2019Q3	nuro	Restricted Cash Collateral Letters Of Credit RestrictedCashCollateralLettersOfCredit	226731	USD
	nuro	Stock Issuance Settle Incentive Compensation Obligation StockIssuanceSettleIncentiveCompensationObligation	294264	USD
	nuro	Stock Issuance Settle Incentive Compensation Obligation StockIssuanceSettleIncentiveCompensationObligation	0	USD
CY2018Q4	nuro	Technology Fees TechnologyFees	450000	USD
CY2019Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	638546	USD
CY2018Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1082957	USD
CY2019Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	523989	USD
CY2018Q4	us-gaap	Accrued Advertising Current And Noncurrent AccruedAdvertisingCurrentAndNoncurrent	171000	USD
CY2019Q3	us-gaap	Accrued Advertising Current And Noncurrent AccruedAdvertisingCurrentAndNoncurrent	373000	USD
CY2018Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2236633	USD
CY2019Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2612907	USD
CY2018Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	391000	USD
CY2019Q3	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	363000	USD
CY2018Q4	us-gaap	Accrued Salaries Current And Noncurrent AccruedSalariesCurrentAndNoncurrent	223756	USD
CY2019Q3	us-gaap	Accrued Salaries Current And Noncurrent AccruedSalariesCurrentAndNoncurrent	133012	USD
CY2018Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	197113646	USD
CY2019Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	197305396	USD
CY2018Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	42805	USD
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	414722	USD
CY2019Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	120460	USD
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	184486	USD
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P1Y9M8D
CY2018Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	25000	USD
CY2019Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	70000	USD
CY2018Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	933523	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	885541	shares
CY2019Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	5050546	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	6020088	shares
CY2018Q4	us-gaap	Assets Assets	13991880	USD
CY2019Q3	us-gaap	Assets Assets	8506777	USD
CY2018Q4	us-gaap	Assets Current AssetsCurrent	11586165	USD
CY2019Q3	us-gaap	Assets Current AssetsCurrent	6635857	USD
CY2018Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6780429	USD
CY2019Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3186636	USD
CY2017Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4043681	USD
CY2018Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	7530598	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6780429	USD
CY2019Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3186636	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	3486917	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-3593793	USD
CY2019Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	416275	shares
CY2018Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2019Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2018Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2019Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2018Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2019Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2018Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	7380463	shares
CY2019Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	9781755	shares
CY2018Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	7380463	shares
CY2019Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	9781755	shares
CY2018Q4	us-gaap	Common Stock Value CommonStockValue	738	USD
CY2019Q3	us-gaap	Common Stock Value CommonStockValue	978	USD
CY2018Q3	us-gaap	Cost Of Revenue CostOfRevenue	1821111	USD
	us-gaap	Cost Of Revenue CostOfRevenue	6726675	USD
CY2019Q3	us-gaap	Cost Of Revenue CostOfRevenue	914322	USD
	us-gaap	Cost Of Revenue CostOfRevenue	6382340	USD
	us-gaap	Depreciation Depreciation	166262	USD
	us-gaap	Depreciation Depreciation	98166	USD
CY2018Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.15
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.40
CY2019Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.14
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.31
CY2018Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.08
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.20
CY2019Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.14
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.31
CY2019Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	25629	USD
CY2018Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1015489	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3990266	USD
CY2019Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1462887	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4646932	USD
CY2018Q3	us-gaap	Gross Profit GrossProfit	1845669	USD
	us-gaap	Gross Profit GrossProfit	5634663	USD
CY2019Q3	us-gaap	Gross Profit GrossProfit	1173679	USD
	us-gaap	Gross Profit GrossProfit	1183279	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	417930	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-659538	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-786986	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-558968	USD
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-146454	USD
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	115752	USD
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	0	USD
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-1956522	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	454779	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	357673	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-425242	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-189092	USD
CY2018Q3	us-gaap	Incremental Common Shares Attributable To Conversion Of Preferred Stock IncrementalCommonSharesAttributableToConversionOfPreferredStock	6584674	shares
	us-gaap	Incremental Common Shares Attributable To Conversion Of Preferred Stock IncrementalCommonSharesAttributableToConversionOfPreferredStock	6847164	shares
CY2019Q3	us-gaap	Incremental Common Shares Attributable To Conversion Of Preferred Stock IncrementalCommonSharesAttributableToConversionOfPreferredStock	0	shares
	us-gaap	Incremental Common Shares Attributable To Conversion Of Preferred Stock IncrementalCommonSharesAttributableToConversionOfPreferredStock	0	shares
CY2018Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	1094190	USD
CY2019Q3	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	545701	USD
CY2018Q4	us-gaap	Inventory Net InventoryNet	2861864	USD
CY2019Q3	us-gaap	Inventory Net InventoryNet	1078653	USD
CY2018Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	1767674	USD
CY2019Q3	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	532952	USD
	us-gaap	Inventory Write Down InventoryWriteDown	0	USD
CY2019Q3	us-gaap	Inventory Write Down InventoryWriteDown	0	USD
	us-gaap	Inventory Write Down InventoryWriteDown	2595884	USD
	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	462917	USD
	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	498073	USD
CY2019Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	2148509	USD
CY2019Q3	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	117431	USD
CY2019Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	641193	USD
CY2019Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	165785	USD
CY2019Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	165785	USD
CY2019Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	247347	USD
CY2019Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	653164	USD
CY2019Q3	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	157804	USD
CY2018Q4	us-gaap	Liabilities Liabilities	7894069	USD
CY2019Q3	us-gaap	Liabilities Liabilities	4933267	USD
CY2018Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	13991880	USD
CY2019Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	8506777	USD
CY2018Q4	us-gaap	Liabilities Current LiabilitiesCurrent	6592897	USD
CY2019Q3	us-gaap	Liabilities Current LiabilitiesCurrent	3914759	USD
	us-gaap	Other Operating Income OtherOperatingIncome	7159464	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	105888	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	41177	USD
	us-gaap	Operating Expenses OperatingExpenses	11059027	USD
CY2018Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-2682628	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-9470431	USD
CY2019Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-1412064	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-9875748	USD
CY2018Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	577460	USD
CY2019Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	585692	USD
CY2018Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1301172	USD
	us-gaap	Line Of Credit Facility Expiration Date1 LineOfCreditFacilityExpirationDate1	2019-11-30
CY2019Q3	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	2500000	USD
CY2019Q3	us-gaap	Line Of Credit Facility Remaining Borrowing Capacity LineOfCreditFacilityRemainingBorrowingCapacity	2300000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	9254	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	7497	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-105888	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-41177	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	3583551	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3560113	USD
CY2018Q3	us-gaap	Net Income Loss NetIncomeLoss	1086058	USD
	us-gaap	Net Income Loss NetIncomeLoss	2826238	USD
CY2019Q3	us-gaap	Net Income Loss NetIncomeLoss	-1404600	USD
	us-gaap	Net Income Loss NetIncomeLoss	-2716284	USD
CY2018Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	1086058	USD
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	2826238	USD
CY2019Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-1404600	USD
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-2716284	USD
CY2018Q3	us-gaap	Operating Expenses OperatingExpenses	4528297	USD
	us-gaap	Operating Expenses OperatingExpenses	15105094	USD
CY2019Q3	us-gaap	Operating Expenses OperatingExpenses	2585743	USD
CY2019Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1018508	USD
CY2018Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1968062	USD
CY2019Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1541975	USD
CY2019Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.15
CY2019Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y9M21D
CY2018Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	133580	USD
CY2019Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	161203	USD
CY2018Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	0	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	0	USD
CY2019Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	0	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	0	USD
CY2018Q3	us-gaap	Other Income OtherIncome	18686	USD
	us-gaap	Other Income OtherIncome	40965	USD
CY2019Q3	us-gaap	Other Income OtherIncome	7464	USD
	us-gaap	Other Income OtherIncome	42797	USD
CY2018Q3	us-gaap	Other Operating Income OtherOperatingIncome	3768686	USD
	us-gaap	Other Operating Income OtherOperatingIncome	12296669	USD
CY2019Q3	us-gaap	Other Operating Income OtherOperatingIncome	7464	USD
CY2018Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	860915	USD
CY2019Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	672487	USD
CY2018Q4	us-gaap	Prepaid Expense And Other Assets Noncurrent PrepaidExpenseAndOtherAssetsNoncurrent	30314	USD
CY2019Q3	us-gaap	Prepaid Expense And Other Assets Noncurrent PrepaidExpenseAndOtherAssetsNoncurrent	29650	USD
	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	9254	USD
	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	7497	USD
CY2018Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	129837	USD
CY2019Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	299295	USD
	us-gaap	Provision For Lease Losses ProvisionForLeaseLosses	125000	USD
CY2019Q3	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	92000	USD
CY2018Q3	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	9254	USD
	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	9254	USD
	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	7497	USD
	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	294264	USD
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	13863953	shares
CY2018Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1178468	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4074895	USD
CY2019Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	475137	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2365139	USD
CY2019Q2	us-gaap	Restructuring And Related Cost Number Of Positions Eliminated RestructuringAndRelatedCostNumberOfPositionsEliminated	11
CY2019Q2	us-gaap	Restructuring Charges RestructuringCharges	2300000	USD
CY2019Q2	us-gaap	Restructuring Charges RestructuringCharges	2300000	USD
CY2019Q3	us-gaap	Restructuring Reserve RestructuringReserve	125000	USD
CY2018Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-191016591	USD
CY2019Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-193700000	USD
CY2019Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-193732875	USD
CY2018Q3	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	3666780	USD
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	12361338	USD
CY2019Q3	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	2088001	USD
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	7565619	USD
CY2018Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	2334340	USD
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	7039933	USD
CY2019Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	647719	USD
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	4046956	USD
CY2019Q2	us-gaap	Severance Costs1 SeveranceCosts1	224773	USD
	us-gaap	Severance Costs1 SeveranceCosts1	224773	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	414722	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	184486	USD
CY2018Q2	us-gaap	Stockholders Equity StockholdersEquity	7721608	USD
CY2018Q3	us-gaap	Stockholders Equity StockholdersEquity	8859725	USD
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	6097811	USD
CY2019Q2	us-gaap	Stockholders Equity StockholdersEquity	4857650	USD
CY2019Q3	us-gaap	Stockholders Equity StockholdersEquity	3573510	USD
CY2018Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	13949712	shares
CY2019Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9781755	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	8863159	shares
CY2018Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	7365038	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	7016789	shares
CY2019Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9781755	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	8863159	shares
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Reclassifications</font></div><div style="line-height:120%;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Certain prior period amounts have been reclassified to conform to the current period presentation. </font></div></div>
	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div><div style="line-height:120%;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make significant estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during reporting periods. Actual results could differ from those estimates.</font></div></div>

Files In Submission

Name	View Source	Status
0001628280-19-012340-index-headers.html	Edgar Link	pending
0001628280-19-012340-index.html	Edgar Link	pending
0001628280-19-012340.txt	Edgar Link	pending
0001628280-19-012340-xbrl.zip	Edgar Link	pending
a10q9302019document.htm	Edgar Link	pending
a10q9302019ex101.htm	Edgar Link	pending
a10q9302019ex311.htm	Edgar Link	pending
a10q9302019ex312.htm	Edgar Link	pending
a10q9302019ex32.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
nuro-20190930.xml	Edgar Link	completed
nuro-20190930.xsd	Edgar Link	pending
nuro-20190930_cal.xml	Edgar Link	unprocessable
nuro-20190930_def.xml	Edgar Link	unprocessable
nuro-20190930_lab.xml	Edgar Link	unprocessable
nuro-20190930_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R9999.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NURO
NeuroMetrix, Inc. Stock $nuro

2019 Q4 Form 10-Q Financial Statement

#000162828019012340 Filed on October 17, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NURO NeuroMetrix, Inc. Stock $nuro

2019 Q4 Form 10-Q Financial Statement

#000162828019012340 Filed on October 17, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NURO
NeuroMetrix, Inc. Stock $nuro